In July 1983, Levin and his colleagues in London described 10 infants with a new fulminating and often fatal disease. All were aged between 3 and 8 months. The fact that the cases occurred within a 12-month period suggested an epidemic. Reports of cases in other centres have followed (Lafeber et al. 1983 , Morris & Matthews 1983 . The clinical features are distinctive, and the sequence of events remarkably similar in each case. An infant, either perfectly well or with mild nonspecific prodromal symptoms, is found collapsed and convulsing. Shock, hypotension, poor peripheral circulation, metabolic acidosis and a moderately elevated core temperature are rapidly followed by profuse bloody diarrhoea and bleeding from venepuncture sites. Biochemical evidence of renal and hepatic impairment is present. Intensive support with ventilation, volume replacement, correction of the coagulation disorder and anticonvulsants is nevertheless followed by death in most cases and survival with severe handicap in a few. The existence of mild cases has been suggested (Schrager & Shah 1983 , McGucken 1983 .
In all cases of the haemorrhagic shock and encephalopathy (HSE) syndrome, collapse and coma are early features, accompanied by convulsions and signs of raised intracranial pressure. CT scans show cerebral oedema, and electroencephalography shows severe diffuse abnormalities. At necropsy the brain is soft and oedematous, with haemorrhage into the pituitary gland. All survivors are severely brain damaged, and many have cortical blindness.
Profound shock, severe hypotension and poor peripheral perfusion, complicated by profuse watery (or bloody) diarrhoea, lead to metabolic acidosis and compensatory respiratory alkalosis. These can be corrected with large volumes of plasma.
Fever is a constant feature, usually with a modest elevation of the rectal temperature (38-39°C) but occasionally reaching 39.5°C or higher.
Vomiting is noted as a prodromal feature in about a third of the cases. Profuse watery or bloodstained diarrhoea quickly develops.
'Arising from case presentation to Section of Paediatrics, 25 November 1983 Bloodstaining of nasogastric asi t eicur.
Bleeding from venepuncture sites an from the gut, kidneys or respiratory tract) early in the illness is accompanied by a prolonged prothrombin time, a prolonged partial thromboplastin time, a reduced plasma fibrinogen, and an elevated level of fibrin degradation products. Damaged red cells are seen on a blood film, and these features of disseminated intravascular coagulation are followed by thrombocytopenia and a fall in the haemoglobin concentration. Treatment with fresh frozen plasma is required, sometimes accompanied by transfusion of platelets or even exchange transfusion with fresh blood.
In all cases there is abnormal renal function with an elevated plasma urea and creatinine but these return to normal after correction of the fluid deficit. Renal tubular necrosis, a feature seen at necropsy, is attributable to profound shock.
In all cases there is a transient elevation of plasma alanine transferase and aspartate transaminase, and a mild elevation of plasma bilirubin. Plasma ammonia levels are normal or mildly elevated, unlike Reye's syndrome where the plasma ammonia level is usually higher. Levels of plasma alkaline phosphatase are normal. Easily controlled hypoglycaemia is an occasional feature.
All these individual features can be seen in a number of other disorders including the toxic shock syndrome, septicaemia, heatstroke and overwhelming viral infections. All of these diseases can be distinguished from the HSE syndrome, but the dividing line between HSE and Reye's syndrome is occasionally not quite so clear. Reye's syndrome is a severe acute disorder characterized by encephalopathy, cerebral oedema, and diffuse fatty infiltration of the viscera, especially the liver (Devivo & Keating 1976 ). Shock and a normal blood ammonia concentration are not, of course, features of Reye's syndrome, although there are a few reports of a normal blood ammonia concentration in Reye's syndrome. At necropsy HSE is easily distinguished by the complete absence of the fatty changes in the liver, kidneys and heart so distinctive of Reye's syndrome. We have recently seen two further infants with all the clinical and biochemical features of HSE. Blood ammonia concentrations were normal in one and mildly elevated in the other. Neither infant had hepatomegaly or hypoglycaemia. Necropsy in both showed the typical fatty liver of Reye's syndrome. A low blood factor VII level was a pointer to hepatic pathology in one. Whilst similar diagnostic problems may have occurred in one or two other cases, most cases of HSE come to necropsy where Reye's syndrome is easily excluded.
The strong clinical impression is that this is a new disease. The aetiology is obscure. Extensive bacteriological and virological studies have failed to discover a causative agent. Morris (1983) was impressed by a similarity between HSE and the staphylococcal toxic shock syndrome, and proposed that HSE may be attributable to a bacterial toxin. It was also suggested that as maternal IgG protects infants in the first few weeks of life, after this initial period they are vulnerable to an unspecified toxin-producing bacterium (Morris 1983) . One of our patients was a 14-day-old (full-term) baby, younger than any reported case, which suggests that the age distribution may not be so restricted. Raised plasma concentrations of immunoreactive trypsin in the face of lowered plasma concentrations of alpha-l-antitrypsin have been reported (Levin et al. 1983 ). It has been suggested that a low alpha-1-antitrypsin may allow circulating immunoreactivetrypsin to cause destruction of the microcirculation, and that this may be important in the pathogenesis of the disease. However, we suspect that the elevated immunoreactive trypsin is probablya nonspecific' feature of renal impairment. The suggestion that the condition is due to heatstroke (Bacon 1983 ) caused by excessive wrapping of the child (Bacon et al. 1979 ) is supported neither by the only modest elevation of core temperature nor by the absence of history of over-wrapping in most cases.
Epidemiological studies are in progress, and paediatricians in the UK are asked to report cases to the PHLS Communicable Disease Surveillance Centre (61 Colindale Road, London NW9 5EQ).
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University of Manchester Argon laser in the treatment of port wine stains' Soon after the first laser was produced by T H Maiman in 1960, it became apparent that the skin provided an excellent test model for the investigation of the effects of laser radiation on living tissues. Research began with the pulsed ruby laser and continued with the argon, carbon dioxide and neodymium YAG lasers which were subsequently developed. A laser (light amplification by stimulated emission of radiation) produces coherent light, an intense beam of pure, collimated monochromatic light, in which all the light waves travel in phase and in the same direction. The lasing medium, which in most medical lasers is a gas, is contained in the laser tube which has, at one end, a fully reflective mirror and, at the other, a partially reflective mirror which allows access to the laser beam. The lasing medium is excited to invert the normal population ratio of excited to non-excited particles which normally has a large excess in the non-excited state. An excited particle will decay to the low-energy ground state with the emission of a photon, a quantum of radiant energy or a light particle. If this photon strikes an excited particle of the lasing medium, it causes it to decay to the ground state and to emit an identical photonstimulated emission. The photons are reflected back into the medium from the mirrors causing further stimulated emission with a rapid build-up of light energy in the laser tubethe cascade effect.
Each laser produces essentially one wavelength of coherent light, which is determined by the lasing medium. The wavelength determines the pattern of absorption of the light when it strikes body tissues and this defines the clinical role of each laser. To change clinical role one must change laser, although there is some overlap in the clinical roles of the three most commonly used lasers.
The carbon dioxide laser is a high precision, bloodless, light scalpel which can be used for the excision or vaporization of lesions, with sealing of blood vessels of up to 0.5 mm in diameter. The neodymium YAG laser is deeply absorbed and can be used for thermal destruction of tissues and for the coagulation of blood vessels. The argon laser produces blue/green coherent light at several wavelengths, but the majority of energy is at 488 and 514 nm. This beam is absorbed by structures with its complementary colour red, but will pass through clear structures without absorption and without thermal damage. 'Paper read to Section of Ophthalmology, 9 February 1984 0 141-0768/84/090722-03/$O 1.00/0
